Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05087524 · ClinicalTrials.gov registry record · NA
BinaxNOW for Evaluating Children for Infection With SARS-CoV-2 (COVID-19)
A NA study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT05087524 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 65 participants.
The verdict
NCT05087524, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
This is a study of the BinaxNOW Covid-19 Ag Card as a method to rapidly identify SARS-CoV-2 infection in asymptomatic children, teachers, and other school staff for exclusion. 240 students and 80 teachers in the Madison Metropolitan School District (MMSD) will be enrolled and can expect to be on study for up to 8 weeks.
Interventions
- DIAGNOSTIC_TEST BinaxNOW Ag Card
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2021-01-09 |
| Est. Completion | 2021-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05087524
The ClinicalTrials.gov registry entry for NCT05087524 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BinaxNOW Ag Card is the first listed.
NCT05087524 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05087524 about?
NCT05087524 is a clinical study titled "BinaxNOW for Evaluating Children for Infection With SARS-CoV-2 (COVID-19)". This is a study of the BinaxNOW Covid-19 Ag Card as a method to rapidly identify SARS-CoV-2 infection in asymptomatic children, teachers, and other school staff for exclusion. 240 students and 80 teachers in the Madison Metropolitan School District (MMSD) will be enrolled and can expect to be on stu...
What is the current status of trial NCT05087524?
This trial is currently terminated. It is a NA study. The enrollment target is 65 participants. The study started on 2021-01-09. Estimated completion is 2021-04-08.
What interventions are being tested in trial NCT05087524?
The interventions under investigation include: BinaxNOW Ag Card (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05087524?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.